Diabetes Mellitus Clinical Trial
Official title:
Patient Education in NorthTrondelag Hospital Trust - Interventions, Effects and Patient Experience
The purpose of this randomised open study is to examine the effect of self-management program for diabetes patients.
| Status | Completed |
| Enrollment | 146 |
| Est. completion date | November 2008 |
| Est. primary completion date | November 2008 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 90 Years |
| Eligibility |
Inclusion Criteria: - Diagnosed with ICPC-2, code T89 - diabetes dependent on insulin and T90 diabetes not dependent on insulin Exclusion Criteria: - Diagnosed with ICPC-2, code T89 - diabetes mellitus juvenile and diabetes I - Attended self-management program previous 12 months |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
| Country | Name | City | State |
|---|---|---|---|
| Norway | Nord-Trondelag Hospital Trust | Levanger | Nord-Trondelag |
| Lead Sponsor | Collaborator |
|---|---|
| Norwegian University of Science and Technology | Central Norway Regional Health Authority |
Norway,
Rygg LØ, Rise MB, Grønning K, Steinsbekk A. Efficacy of ongoing group based diabetes self-management education for patients with type 2 diabetes mellitus. A randomised controlled trial. Patient Educ Couns. 2012 Jan;86(1):98-105. doi: 10.1016/j.pec.2011.04 — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | HbA1c | Baseline, 6, and 12 mds | No | |
| Primary | PAM - Patient activation measure | Baseline, 6, and 12 mds | No | |
| Secondary | SF36 | Baseline, 6, and 12 mds | No | |
| Secondary | EQ 5D-VAS scale | Baseline, 6, and 12 mds | No | |
| Secondary | Hunt diabetes | Baseline, 6, and 12 mds | No | |
| Secondary | WHO-DTSQ | Baseline, 6, and 12 mds | No | |
| Secondary | Knowledge of diabetes | Baseline, 6, and 12 mds | No | |
| Secondary | HDL-cholesterol | Baseline, 6, and 12 mds | No | |
| Secondary | Total cholesterol | Baseline, 6, and 12 mds | No | |
| Secondary | Creatinin | Baseline, 6, and 12 mds | No | |
| Secondary | Blood pressure | Baseline, 6, and 12 mds | No | |
| Secondary | Weight | Baseline, 6, and 12 mds | No | |
| Secondary | BMI | Baseline, 6, and 12 mds | No | |
| Secondary | Cost/benefit | Baseline, 6, and 12 mds | No | |
| Secondary | Triglyceride | Baseline, 6, and 12 mds | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |